Phase 1 Open Label Trial of the Safety, Tolerability, and Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Solithromycin (Primary)
- Indications Gonorrhoea
- Focus Pharmacokinetics
- 26 Jan 2017 Status changed from recruiting to completed.
- 14 Apr 2016 Trial focus changed from AR,PK to PK. Endpoints, Exclusion criteria and treatment amended.
- 14 Apr 2016 Planned End Date changed from 1 Jan 2016 to 1 Sep 2016.